I n the beginning (in 2013), there was a request for applications to create a new American Gastroenterological Association (AGA) basic science journal. My previous editorial experience made this an interesting challenge. Jim Goldenring, Becky Wells, and I created an application that expressed our vision of what the journal could be. We anticipated that the primary audience would be similar to those who read basic and translational science in Gastroenterology, Hepatology, and others. This would require that published reports represent exceptional science and qualify for publication in a journal supported by the AGA brand. We noted a large gap between the top journals in our field and the next tier. Given the external forces that were making it harder to publish outstanding basic and translational research in gastroenterology, hepatology, and pancreatology in top tier journals, we concluded that there was a pressing need for a journal that could fill that gap.
In addition to publishing outstanding research, we considered fair, ethical, and open interactions with authors to be requisite core principles for the new journal. To guarantee equitable and uniform treatment of submitted manuscripts, regardless of the assigned editor, we decided that regular review meetings would be essential. We also sought to develop a highly efficient, author service-focused review system with rapid turnaround. To ensure transparency within the review process, we resolved to include complete explanations in all decision letters and to make editors available for further discussion. Several other current publishing practices that we deemed in need of change also were identified, including incomplete Methods sections (to save space), references limited to general reviews (instead of the primary literature), and progressive expansion of supplementary materials (often to satisfy reviewers). We therefore created 3 founding principles for the journal:
1. The journal would focus on high-quality, mechanistically oriented, basic and translational research relevant to biology and disease of the gastrointestinal tract, liver, and pancreas.
2. Manuscript formats would promote reproducibility and rigor with complete data presentation and literature citation, thereby avoiding excessive requests for supplementary data.
3. Author service would include a rapid, fair, and transparent review process, low publication costs, and open access without additional fees.
Several names for the new journal were considered. In the end, we selected Cellular and Molecular Gastroenterology and Hepatology to parallel and synergize with the AGA clinical practice journal Clinical Gastroenterology and Hepatology. We knew that the name would be cumbersome to say and, from the beginning, expected the journal to be known as CMGH. This became a key point when working with the AGA's senior creative director, Matthew Nickols. I do not know how many iterations were required, but Matthew was creative, insightful, and, most of all, patient as we worked to develop the look of CMGH, including the layout and color schemes of the cover and inside pages. It was Matthew who created the now familiar "cmgh" logo that has come to represent the journal's brand.
Jim, Becky, and I had all served as associate editors before, however, these positions had been at established journals; creating a new journal was uncharted territory. Everything had to be decided. How would the articles be formatted? What types of articles would be permitted? Would the pages be set as 2 columns or 3? How many authors would be listed in the references? At first, the details seemed to never end, and, personally, I spent many sleepless nights wondering what I had forgotten. Fortunately, our Managing Editor and AGA Director of Publications, Lindsey Brounstein, worked incessantly to ensure everything was done well. We also received tremendous support and advice from Erin Landis, AGA Vice President of Publications.
We also worried about submissions. Who would have enough faith in an upstart journal to submit their own outstanding work? The research community responded. The call for submissions to be considered for the inaugural issue had a robust response. Reasoning that initial submissions might be limited, we also asked thought-leaders to write insightful reviews. We encouraged them to share their opinions; after all, why ask experts to write reviews? Sarah Williamson, AGA's Senior Medical Illustrator, drew beautiful figures for these reviews and established the CMGH style. The first issue, in January 2015, included 4 original articles and 4 review articles. To date, all have been cited and, as a group, these 8 articles have been cited more than 150 times. The second issue of CMGH, published only 2 months later, included 2 reviews, 5 original articles, and, including editorials and commentaries, a total of 12 articles that have been cited more than 200 times. Thus, with substantial contributions from many, including the Editorial Board, ad hoc reviewers, and authors, and a little luck, CMGH was off to a strong start. When we look at the journal today, it is hard to believe that it is only 4 years old. This rapid growth reflects the tremendous enthusiasm support CMGH has received from the gastrointestinal, liver, and pancreatic research community.
Since those early days, the original team has been joined by others, all of whom have made essential contributions. These include Maria Rescigno, who joined us as an Associate Editor as submissions grew (there were more than 230 original submissions in the past 12 months); our Publisher George Woodard and Journal Manager Robin Vadel from Elsevier, and numerous AGA staff including Assistant Managing Editor Ryan Farrell and Publications and Digital Media Coordinator Alexander Vaeth.
Throughout the process, there have been challenges and rewards. These included successful applications for inclusion in PubMed Central, MEDLINE, and Web of Science, and never-ending efforts toward author service and innovation. For example, Elsevier printed a mini-issue containing highlights from the first year of publication, 2015, for distribution at Digestive Disease Week 2016 and other meetings. Since then, the number of articles and topics covered has grown to the extent that Elsevier has agreed to print 3 miniissues each year. In addition to being distributed at Digestive Disease Week meetings, these have been sent to many AGA members along with their Gastroenterology subscriptions. In 2017, CMGH introduced graphical abstracts, which are now included in almost all original articles. The first CMGH special issue, which focused on "Organoids and Engineered Organ Systems," was created by Guest Editors Linda Samuelson and John Lynch and completed in 2018. In the same year, CMGH introduced the Research Letter as a compact format for authors with exciting new observations.
In the past year I have talked to several younger scientists who were aware of CMGH but did not know that it was a new journal. More senior investigators have commented to me that they are impressed by the quality of articles within CMGH and look forward to the publication of each issue. These conversations are incredibly reassuring. They provide evidence that the journal is becoming established as a high-quality forum for basic and translational research in gastroenterology, hepatology, and pancreatology. Data also indicate that we have succeeded in our goal of treating authors as colleagues. For example, CMGH has received thank you emails from authors whose submissions were rejected, something I did not expect. These authors noted that, despite the outcome, the feedback provided by the CMGH review process was helpful as their work continued.
The question the Associate Editors and I are asked most often is, "when will CMGH have an impact factor?" We finally know that the answer is summer 2020. This is, perhaps, the only real disappointment of our tenure. Unfortunately, the ever-increasing number of new journals prompted Clarivate to convert a 1-step process into a 2-step process. As a result, CMGH was included in the Emerging Sources Citation Index at the end of 2017, but acceptance into the Web of Science was not completed until this year. The latter is required for Clarivate to calculate an impact factor. Because CMGH was included after January 1, 2019, the impact factor will not be calculated this year. That said, we have performed careful internal tracking for several years. On the basis of these data, we are confident that authors and readers will be pleased with the official impact factor once it is released. Moreover, our data indicate that CMGH has succeeded in filling the gap we had identified and provided a highlyregarded venue for publication of exceptional work.
Personally, I have mixed emotions about stepping down as Editor-in-Chief. Leading the team that created CMGH has been a gratifying adventure. I have had the opportunity to work with great people and, I hope, to make a scientific contribution beyond the walls of my own laboratory. Staying on would only postpone the inevitable. After all, even centenarian Herb Tabor who served as Editor-in-Chief of the Journal of Biological Chemistry from 1971 to 2012 stepped down eventually. Personally, I look forward to using my browser bookmark for "CMGH editorialmanager" less often and having a bit more time on Monday mornings (the time of our weekly Board of Editors call), but will miss the camaraderie that has grown within the entire CMGH team.
In reflection, establishing CMGH has required an incredible amount of energy and devotion, from others as well as myself. These efforts have been rewarded with excitement and inspiration. All in all, I am grateful to have had the opportunity and recommend it to others. I am delighted that incoming Co-Editors-in-Chief Michael Pack and Klaus Kaestner will be taking the reigns of CMGH, and I am certain they will bring innovative ideas and take the journal to new heights. I look forward to the continued success of CMGH under their leadership.
The genesis of CMGH has been a team effort, and represents contributions by many members of the CMGH family, including editors, staff, editorial and advisory board members, reviewers, and authors. With gratitude,
